Sign In
Buy PMCUF
$114.09
+18.69 (+19.59%)
At Close: Jun 03, 2026
Pro Medicus Limited (OTCMKTS:PMCUF) Sees Large Decrease in Short Interest
02:12pm, Sunday, 05'th Dec 2021 Transcript Daily
Pro Medicus Limited (OTCMKTS:PMCUF) was the recipient of a large decline in short interest in November. As of November 15th, there was short interest totalling 7,300 shares, a decline of 22.3% from the October 31st total of 9,400 shares. Based on an average trading volume of 500 shares, the days-to-cover ratio is currently 14.6 days. []
Australian sharemarket volatility continues, pharmacy owner and Pro Medicus top best in ASX200
07:11am, Friday, 03'rd Dec 2021 Perth Now
The ASX continued its rollercoaster ride, clawing back losses once again in a volatile session, with banks and resources stocks proving the positive backbone.
Australian sharemarket volatility continues, pharmacy owner and Pro Medicus top best in ASX200
07:11am, Friday, 03'rd Dec 2021 The West Australian
The ASX continued its rollercoaster ride, clawing back losses once again in a volatile session, with banks and resources stocks proving the positive backbone.
Visage Speeds Ahead with CloudPACS at RSNA 2021
07:44pm, Tuesday, 16'th Nov 2021 Business Insider Markets
SAN DIEGO, Nov. 16, 2021 /PRNewswire/ -- Visage Imaging, Inc. ("Visage"), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced it will be showcasing the latest version of the Visage ® 7 Enterprise Imaging Platform, purpose built
Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript
04:37am, Wednesday, 18'th Aug 2021
Pro Medicus' (PMCUF) CEO Sam Hupert on Q4 2021 Results - Earnings Call Transcript
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript
11:09pm, Tuesday, 16'th Feb 2021
Pro Medicus Limited (PMCUF) CEO Sam Hupert on Q2 2021 Results - Earnings Call Transcript
